new glp-1 weight loss drug helps patients lose an average of 50 pounds Dozens of new obesity drugs

Jumping into intense workouts too soon does not accelerate weight loss

The approval of orforglipron signals both a shift toward more accessible obesity treatments and a test case for the FDAs new accelerated review pathway

How much GLP-1 do you take depends on the specific medication prescribed, your treatment indication (type 2 diabetes or weight management), and your individual response to therapy

doi: 10.1039/c9fo02992c 147 QiaoHZhaoTYinJZhangYRanHChenSet al

For the majority of patients without pre-existing cardiac conditions, this is not dangerous

They can activate the same reward centers that addictive drugs do